Richard Malamut
Vermögen: 753 389 $ am 31.05.2026
Vermögen: 753 389 $ am 31.05.2026
Richard Malamut is currently an Independent Director at Pelthos Therapeutics, Inc. since 2023 and Chief Medical Officer at MedinCell SA since 2022.
Former positions include Independent Director at Channel Therapeutics Corp.
and Chromocell Therapeutics Corp., Vice President-Global Clinical Development at Teva Pharmaceutical Industries Ltd. from 2013 to 2016, Chief Medical Officer & Executive Vice President at Collegium Pharmaceutical, Inc. from 2019 to 2022, Chief Medical Officer & Senior Vice President at Braeburn, Inc. from 2018 to 2019, and Chief Medical Officer at Avanir Pharmaceuticals, Inc. from 2016 to 2018.
Education includes a doctorate from Hahnemann University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,82 % | 02.04.2026 | 28.462 ( 0,82 % ) | 753 389 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDINCELL S.A. | Technik-/Wissenschafts-/F&E-Leiter | 09.05.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.03.2022 |
| BRAEBURN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
| AVANIR PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.11.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Hahnemann University
Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
Chromocell Therapeutics Corp.
Chromocell Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which develops and commercializes new therapeutics to alleviate pain | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen